Regeneron Pharmaceuticals (REGN) News Today $525.00 +4.00 (+0.77%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock REGN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Regeneron Pharmaceuticals (NasdaqGS:REGN) Exits Multiple Russell Growth IndicesJune 30 at 5:20 PM | finance.yahoo.comRegeneron Pharmaceuticals (NASDAQ:REGN) Downgraded to Hold Rating by ArgusJune 30 at 9:18 AM | marketbeat.comRedJay Asset Management Inc. Invests $1.27 Million in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)June 30 at 9:03 AM | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by KBC Group NVJune 29 at 7:07 AM | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Sumitomo Mitsui Trust Group Inc.June 29 at 5:41 AM | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Cut by Mirae Asset Global Investments Co. Ltd.June 29 at 5:04 AM | marketbeat.comREGN - Regeneron Pharmaceuticals Inc News - MorningstarJune 28 at 3:03 PM | morningstar.comMDiversified Trust Co Acquires 544 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)June 28 at 4:56 AM | marketbeat.comOppenheimer Asset Management Inc. Takes $1.25 Million Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)June 28 at 3:39 AM | marketbeat.comRegeneron’s Phase 3 Trial: A New Hope for Follicular Lymphoma TreatmentJune 27 at 12:56 PM | tipranks.comRegeneron’s Promising Cancer Study: A Closer Look at REGN7075 and CemiplimabJune 27 at 12:56 PM | tipranks.comHunter Perkins Capital Management LLC Acquires Shares of 8,482 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)June 27 at 7:47 AM | marketbeat.comIllinois Municipal Retirement Fund Acquires 2,774 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)June 27 at 7:45 AM | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Loring Wolcott & Coolidge Fiduciary Advisors LLP MAJune 27 at 6:54 AM | marketbeat.comRobeco Institutional Asset Management B.V. Sells 16,813 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)June 27 at 5:01 AM | marketbeat.comRegeneron to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2025June 26, 2025 | globenewswire.comSA analyst upgrades/downgrades: AAPL, FCX, REGN, AMBAJune 26, 2025 | msn.comRegeneron’s New NSCLC Study: Potential Game-Changer in Cancer Treatment?June 26, 2025 | tipranks.comRegeneron’s Innovative Approach: Linvoseltamab in Multiple Myeloma StudyJune 26, 2025 | tipranks.comRegeneron’s Gene-Silencing Study for MASH: A Potential Market Game-ChangerJune 26, 2025 | tipranks.comRegeneron’s Linvoseltamab Trial: A Potential Game-Changer in Multiple Myeloma TreatmentJune 26, 2025 | tipranks.comGlobal Assets Advisory LLC Makes New $443,000 Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)June 26, 2025 | marketbeat.comRegeneron Launches $200 Million Donation Matching Program to Support Vision CareJune 25, 2025 | finance.yahoo.comRegeneron’s Heart Failure Study: A Potential Game-Changer in Cardiovascular TreatmentJune 25, 2025 | tipranks.comRegeneron Pharmaceuticals Stock May Be Worth Buying Again - Rating UpgradeJune 25, 2025 | seekingalpha.comRegeneron: Negative Scenario Is Being Realized (Rating Downgrade)June 25, 2025 | seekingalpha.comAdams Diversified Equity Fund Inc. Has $12.49 Million Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)June 25, 2025 | marketbeat.comAsset Management One Co. Ltd. Purchases 2,358 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)June 25, 2025 | marketbeat.comEnvestnet Portfolio Solutions Inc. Sells 913 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)June 25, 2025 | marketbeat.comRegeneron Pharmaceuticals Inc REGN - MorningstarJune 24, 2025 | morningstar.comMRegeneron’s Aflibercept Study: A Closer Look at Retinal Vasculitis IncidenceJune 24, 2025 | msn.comRegeneron: Potential Entrant To Weight Loss MarketJune 24, 2025 | seekingalpha.comRegeneron Pharmaceuticals Launches $200 Million Donation Matching Program for Good Days’ Retinal FundJune 24, 2025 | quiverquant.comQRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by Cornerstone Wealth Group LLCJune 24, 2025 | marketbeat.comRegeneron Announces First-of-its-Kind Donation Matching Program with Independent Charitable Patient Assistance OrganizationJune 24, 2025 | globenewswire.comChevy Chase Trust Holdings LLC Sells 8,557 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)June 24, 2025 | marketbeat.comOppenheimer & Co. Inc. Purchases 1,369 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)June 24, 2025 | marketbeat.comUBS Lowers Price Target On Regeneron Pharmaceuticals, Inc. (REGN).June 23, 2025 | insidermonkey.comBernstein Reaffirms Their Buy Rating on Regeneron (REGN)June 22, 2025 | theglobeandmail.comWealth Enhancement Advisory Services LLC Sells 13,146 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)June 22, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by Marietta Wealth Management LLCJune 21, 2025 | marketbeat.com557 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Acquired by Sowell Financial Services LLCJune 21, 2025 | marketbeat.comShareholders Approve Bylaw Amendments at Regeneron Pharmaceuticals (NasdaqGS:REGN) Annual MeetingJune 20, 2025 | uk.finance.yahoo.comRetirement Systems of Alabama Raises Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)June 20, 2025 | marketbeat.comSanofi, Regeneron Get FDA Approval for Dupixent to Treat Rare Skin DiseaseJune 20, 2025 | wsj.comDupixent® (dupilumab) Approved in the U.S. as the Only Targeted Medicine to Treat Patients with Bullous Pemphigoid (BP)June 20, 2025 | globenewswire.comPress Release: Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoidJune 20, 2025 | globenewswire.comClarius Group LLC Has $716,000 Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)June 19, 2025 | marketbeat.comQRG Capital Management Inc. Has $2.65 Million Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)June 19, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stake Raised by Janney Montgomery Scott LLCJune 19, 2025 | marketbeat.com Get Regeneron Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for REGN and its competitors with MarketBeat's FREE daily newsletter. Email Address REGN Media Mentions By Week REGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. REGN News Sentiment▼0.810.90▲Average Medical News Sentiment REGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. REGN Articles This Week▼3932▲REGN Articles Average Week Get Regeneron Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for REGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amgen News Gilead Sciences News Vertex Pharmaceuticals News Alnylam Pharmaceuticals News Biogen News Incyte News United Therapeutics News Neurocrine Biosciences News Exelixis News BioMarin Pharmaceutical News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:REGN) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredConsumer apocalypse imminent (7 ominous red flags)The #1 Gold play right now (not a miner, ETF, or bullion) Gold is up 237% since 2008... but one gold invest...Stansberry Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regeneron Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Regeneron Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
